Table 2.
Cohort results for 2014 of camp and non-camp Syrian refugee culture-confirmed patients who started anti-TB treatment 9 months prior
| Tuberculosis cohort findings* by quarter, 2014 | 1st quarter % (n/N) | 2nd quarter % (n/N) | 3rd quarter % (n/N) |
|---|---|---|---|
| Cure/completion rate (without MDR†) | 91 % (21/23) | 96 % (23/24) | 85 % (17/20) |
| Likely to complete treatment (without MDR) | 91 % (21/23) | 100 % (24/24) | 95 % (19/20) |
| Death rate | 0 % (0/0) | 0 % (0/0) | 5 % (1/20) |
| Default treatment rate | 9 % (2/23) | 0 % (0/0) | 0 % (0/0) |
| Fail treatment rate | 0 % (0/0) | 0 % (0/0) | 0 % (0/0) |
*Source definitions: CDC. Understanding the TB cohort review process: instruction guide, 2006. [http://www.cdc.gov/tb/publications/guidestoolkits/cohort/method.htm]
†MDR, multiple-drug resistant